Today, Amgen shared its 2025 second quarter earnings report. Amgen’s employees are united by our mission to serve patients. We harness the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller, and longer.
"We're delivering strong performance and reaching more patients with innovative medicines and biosimilars that address serious diseases. We continue to invest in science that enables longer, healthier lives and supports sustainable, long-term growth," said Bob Bradway, chairman and chief executive officer.
The infographic below provides more highlights about the company’s 2025 second quarter results.
Additional details can be found in the earnings press release. Please see forward-looking statements.
A webcast of the earnings call can be found on Amgen’s Investors page.
